Abruptly discontinuing the medication without guidance could lead to a rise in blood sugar levels or other complications
In the STEP 1 clinical trial, adults who received once-weekly semaglutide alongside lifestyle support lost an average of about 14.9% of their starting body weight over 68 weeks
In some studies, individuals who used both GLP-1 medications and phentermine reported greater weight loss than those who used either medication alone
In type 2 diabetes, nearly every new entrant over the last 20 years has offered an improvement in the low single digits or less
Trumps vow Thursday to bring Ozempic down to $150 per month, calling it the fat-loss drug, sent Novo Nordisk shares down 6.3% A new case series published in JAMA Ophthalmology has spotlighted rare but potentially serious vision issues in patients taking semaglutide or tirzepatide, two popular glucagon-like peptide-1 (GLP-1) receptor agonists commonly used to treat diabetes and aid weight loss
Studies show that bringing glutathione levels back up reduces oxidative stress markers to levels like those in younger individuals
